Randy D. Blakely

C. elegans: a novel pharmacogenetic model to study Parkinson's disease.

R. Blakely, R. Nass, D. Miller, 2001, Parkinsonism & related disorders.

Pharmacological profile of neuroleptics at human monoamine transporters.

R. Blakely, E. Richelson, K. Jansen, 1999, European journal of pharmacology.

Choline on the Move: Perspectives on the Molecular Physiology and Pharmacology of the Presynaptic Choline Transporter.

R. Blakely, E. Ennis, Randy D. Blakely, 2016, Advances in pharmacology.

A re-examination of the interaction of N-acetyl-L-aspartyl-L-glutamate with a subpopulation of rat brain membrane L-[3H]glutamate binding sites.

J. Coyle, R. Blakely, M. Robinson, 1988, European journal of pharmacology.

A requirement of serotonergic p38α mitogen-activated protein kinase for peripheral immune system activation of CNS serotonin uptake and serotonin-linked behaviors

J. T. Smith, E. Deneris, R. Blakely, 2015, Translational Psychiatry.

Cholinergic neurons of mouse intrinsic cardiac ganglia contain noradrenergic enzymes, norepinephrine transporters, and the neurotrophin receptors tropomyosin-related kinase A and p75

R. Blakely, N. Paolocci, D. Hoover, 2008, Neuroscience.

cGMP-dependent protein kinase Iα associates with the antidepressant-sensitive serotonin transporter and dictates rapid modulation of serotonin uptake

Carrie C Buchanan, R. Blakely, Heinrich J.G. Matthies, 2009, Molecular Brain.

Modified structure of the human serotonin transporter promoter

R. Blakely, N. Flattem, Randy D. Blakely, 2000, Molecular Psychiatry.